Published in Scand J Immunol on January 01, 1980
Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis (1985) 1.41
Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J (Clin Res Ed) (1985) 1.31
Kinetic studies of neutrophil phagocytosis. V. studies on the co-operation between the Fc and C3b receptors. Immunology (1982) 0.99
Kinetic studies of phagocytosis. IV. Cellular defects and humoral inhibition as causes of impaired neutrophil phagocytosis in sarcoidosis. Clin Exp Immunol (1982) 0.82
Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera. Immunology (1982) 0.77
Neutrophil phagocytosis in sarcoidosis. Reduced C3b receptor-mediated phagocytosis in active and silent sarcoidosis. Clin Exp Immunol (1985) 0.77
Biosynthesis of glycosaminoglycans and proteoglycans by the lymph node. Glycoconj J (2000) 0.76
The potency of hyaluronan of different molecular weights in the stimulation of blood phagocytes. Mediators Inflamm (2011) 0.75
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med (2000) 4.35
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis (1985) 3.77
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation (1996) 2.91
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol (2001) 2.87
Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature (1986) 2.41
Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood (1974) 2.22
Lipocalins as biochemical markers of disease. Biochim Biophys Acta (2000) 2.08
Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy (2004) 2.03
Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature (1984) 1.75
Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol (1996) 1.73
Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis (1994) 1.73
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med (1999) 1.69
Radioimmunoassay of human eosinophil cationic protein. Br J Haematol (1977) 1.68
Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy (1993) 1.65
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J (1997) 1.65
Bronchial hyperresponsiveness to methacholine in patients with primary Sjögren's syndrome. Ann Rheum Dis (1991) 1.63
Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med (2000) 1.58
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med (1990) 1.56
The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy (1999) 1.55
Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest (1995) 1.51
Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta (2011) 1.49
Regulation of the release of eosinophil cationic protein by eosinophil adhesion. Clin Exp Allergy (2000) 1.48
The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br J Haematol (1997) 1.47
Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects. Eur Respir J (1991) 1.45
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut (2002) 1.45
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med (1996) 1.44
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus (1981) 1.42
Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis (1985) 1.41
IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season. Clin Exp Allergy (2001) 1.41
Activation of B-lymphocytes during pollen season. Effect of immunotherapy. Clin Exp Allergy (1998) 1.40
Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. Ann Thorac Surg (1995) 1.40
The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol (1982) 1.40
Role of hyaluronan in acute pancreatitis. Surgery (2000) 1.39
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis (1993) 1.39
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol (1997) 1.37
Human eosinophil peroxidase: purification and characterization. J Immunol (1985) 1.36
Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism (1988) 1.35
Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding. Acta Neurol Scand (1980) 1.34
Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut (1993) 1.33
The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis (1997) 1.33
Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol (1989) 1.32
Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis (1990) 1.31
Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J (Clin Res Ed) (1985) 1.31
Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Immunology (1995) 1.30
Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res (1979) 1.30
Cationic proteins of human granulocytes. IV. Esterase activity. Lab Invest (1975) 1.28
Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol (1977) 1.25
Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus. Ann Rheum Dis (1976) 1.25
Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.24
Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg (1996) 1.24
Accumulation of hyaluronic acid in the alveolar interstitial tissue in bleomycin-induced alveolitis. Am Rev Respir Dis (1989) 1.24
Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest (1994) 1.23
Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum (1987) 1.23
Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. J Lab Clin Med (1977) 1.22
Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax (1989) 1.21
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21
The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis (1989) 1.21
Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis (1985) 1.20
Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Studies during inhalation challenge test. Allergy (1978) 1.19
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med (2001) 1.18
Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med (1997) 1.17
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol (1991) 1.17
Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res (1999) 1.16
Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis (1986) 1.16
Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis (1986) 1.16
The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol (1988) 1.15
Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy (1991) 1.15
Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. J Immunol (1975) 1.15
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol (1990) 1.14
Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis (1990) 1.12
IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig Dis Sci (2001) 1.12
Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci (1998) 1.12
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11
Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum (1990) 1.11
The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology (1990) 1.11
Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins. Br J Haematol (1978) 1.11
Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat. Eur Respir J (1992) 1.10
Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm Res (1992) 1.10
Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet (1989) 1.10
Nasal and ocular symptoms, tear film stability and biomarkers in nasal lavage, in relation to building-dampness and building design in hospitals. Int Arch Occup Environ Health (1999) 1.10
Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. Metabolism (1987) 1.10
Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation (1990) 1.09
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol (1996) 1.09
Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. Scand J Haematol (1979) 1.08